{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:18:16Z","timestamp":1793906296782,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vaccine.2024.04.077","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T08:20:41Z","timestamp":1714983641000},"page":"3655-3663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Insufficient vaccine coverage and vaccine hesitancy in people living with HIV: A prospective study in outpatient clinics in the Paris region"],"prefix":"10.1016","volume":"42","author":[{"given":"Agnieszka","family":"Kolakowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa\u00efe","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evguenia","family":"Krastinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Caby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7682-0115","authenticated-orcid":false,"given":"David","family":"Zucman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Maka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Ch\u00e9ret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.077_b0005","unstructured":"Haut Conseil de la sant\u00e9 publique. Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations 1\u00e8re \u00e9dition \u2013 2012."},{"key":"10.1016\/j.vaccine.2024.04.077_b0010","unstructured":"Haut Conseil de la sant\u00e9 publique. Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations. 2\u00e8me \u00e9dition \u2013 D\u00e9cembre 2014."},{"key":"10.1016\/j.vaccine.2024.04.077_b0015","unstructured":"World Health Organization Europe. Edited by Irina Eramova, Srdan Matic and Monique Munz. HIV\/AIDS treatment and care: clinical protocols for the WHO European region. 2007. Acc\u00e8s Internet le 12\/11\/2019.http:\/\/www.euro. who.int\/__data\/assets\/pdf_file\/0004\/78106\/E90840. pdf."},{"key":"10.1016\/j.vaccine.2024.04.077_b0020","unstructured":"World Health Organization. Vaccine position papers. http:\/\/www.who.int\/immunization\/documents\/positionpapers\/en\/. Accessed Nov 12, 2019."},{"key":"10.1016\/j.vaccine.2024.04.077_b0025","unstructured":"British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults, (2015) http:\/\/www.bhiva.org\/vaccination-guidelines.aspx."},{"key":"10.1016\/j.vaccine.2024.04.077_b0030","doi-asserted-by":"crossref","unstructured":"Kim, D. K., Riley, L. E., Harriman, K. H., Hunter, P. & Bridges, C. B. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older \u2014 United States, 2017. 66, 3 (2017).","DOI":"10.7326\/M16-2936"},{"key":"10.1016\/j.vaccine.2024.04.077_b0035","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.077_b0040","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. https:\/\/aidsinfo.nih. gov\/contentfiles\/lvguidelines\/adult_OI.pdf. Accessed Nov 12, 2019."},{"key":"10.1016\/j.vaccine.2024.04.077_b0045","unstructured":"European AIDS Clinical Society (EACS) Guidelines for the treatment of HIV. Version 10.0 November 2019. http:\/\/www.eacsociety.org\/guidelines\/eacs-guide lines\/eacs-guidelines.html. Accessed Nov 16, 2019."},{"key":"10.1016\/j.vaccine.2024.04.077_b0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/cid\/ciu979","article-title":"Seasonal influenza vaccination rates in the HIV outpatient study-United States, 1999\u20132013","volume":"60","author":"Durham","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.077_b0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jinf.2010.04.004","article-title":"Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults","volume":"61","author":"Molton","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2024.04.077_b0060","doi-asserted-by":"crossref","first-page":"e49314","DOI":"10.1371\/journal.pone.0049314","article-title":"Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study","volume":"7","author":"Price","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.077_b0065","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.ijid.2008.05.1226","article-title":"Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults","volume":"12","author":"Bailey","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.077_b0070","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2015.06.056","article-title":"Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria","volume":"33","author":"Grabmeier-Pfistershammer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0075","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1016\/j.vaccine.2014.07.114","article-title":"High need for MMR vaccination in HIV infected adults in Austria","volume":"32","author":"Grabmeier-Pfistershammer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0080","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1080\/21645515.2021.1894895","article-title":"The coverage of influenza and pneumococcal vaccinations among people living with HIV in Denmark: A single-center cross-sectional survey","volume":"17","author":"Larsen","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.04.077_b0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.21101\/cejph.a5830","article-title":"Cross-sectional study on vaccination coverage in newly diagnosed HIV-infected persons in the Czech Republic","volume":"27","author":"Jilich","year":"2019","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.vaccine.2024.04.077_b0090","article-title":"Pr\u00e9valence de l\u2019infection par le virus de l\u2019h\u00e9patite B (VHB) et couverture vaccinale contre le VHB chez les hommes ayant des relations Sexuelles avec des hommes fr\u00e9quentant des lieux de convivialit\u00e9\u0301 gay De cinq villes fran\u00e7aises","author":"Vaux","year":"2015","journal-title":"\u00c9tudes prevagay"},{"issue":"32","key":"10.1016\/j.vaccine.2024.04.077_b0095","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/j.vaccine.2016.03.024","article-title":"HIV care: A missed opportunity for immunization","volume":"34","author":"Gagneux-Brunon","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.077_b0100","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.medmal.2017.03.309","article-title":"Couverture vaccinale dans une cohorte de patients vivant avec le VIH suivis dans un CHU : \u00e9tude prospective transversale, 25 janvier\u201312 f\u00e9vrier 2016, France","volume":"47","author":"Leclere","year":"2017","journal-title":"M\u00e9decine Mal Infect"},{"key":"10.1016\/j.vaccine.2024.04.077_b0105","unstructured":"D\u2019Ornellas, N. \u00c9valuation de la couverture vaccinale des patients vivant avec le VIH suivis en centre hospitalier r\u00e9gional, \u00e9tude prospective transversale, novembre 2016 \u2013 juin 2017."},{"key":"10.1016\/j.vaccine.2024.04.077_b0110","doi-asserted-by":"crossref","unstructured":"Morineau Le Houssine P, S\u00e9cher S, Jovelin T, Allavena C, Hall N, Bouchez S, Billaud E, Bernaud C, Brunet-Cartier C, Besnier M, Reliquet V, Bonnet B, Brochard J, Boutoille D, Coutherut J, Biron C, Raffi F. Etude transversale de la couverture vaccinale dTP, grippe, pneumocoque et h\u00e9patique B des patients VIH suivis dans un service de maladies infectieuses et tropicales d\u2019un CHU. M\u00e9decine et Maladies Infectieuses. Volume 48, Issue 4, Supplement. June 2018, Pages S139-S140.","DOI":"10.1016\/j.medmal.2018.04.348"},{"key":"10.1016\/j.vaccine.2024.04.077_b0115","series-title":"COVARISQ (estimation de la COuverture VAccinale des adultes \u00e0 RISQues): taux de vaccination des immunod\u00e9prim\u00e9s en France en 2017","author":"Wyplosz","year":"2020"},{"key":"10.1016\/j.vaccine.2024.04.077_b0120","doi-asserted-by":"crossref","unstructured":"Durstenfeld, M. S. et al. Impact of HIV Infection on COVID-19 Outcomes Among Hospitalized Adults in the U.S. http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.04.05.21254938 (2021) doi:10.1101\/2021.04.05.21254938.","DOI":"10.1101\/2021.04.05.21254938"},{"key":"10.1016\/j.vaccine.2024.04.077_b0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijid.2022.10.005","article-title":"Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis","volume":"124","author":"Yin","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.077_b0130","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1016\/j.vaccine.2023.07.043","article-title":"Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study","volume":"41","author":"Moscara","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0135","volume":"73","author":"Groupe de Travail Inter-COREVIH","year":"2018","journal-title":"Epid\u00e9miologie du VIH en Ile de France"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.077_b0140","first-page":"51","article-title":"La couverture vaccinale dipht\u00e9rie, t\u00e9tanos, poliomy\u00e9lite chez l\u2019adulte en France: r\u00e9sultats de l\u2019enqu\u00eate Sant\u00e9 et Protection sociale, 2002","volume":"441","author":"Guthmann","year":"2007","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.vaccine.2024.04.077_b0145","unstructured":"Guthmann JP. Enqu\u00eate nationale de couverture vaccinale, France, janvier 2011. Couverture vaccinale contre la grippe saisonni\u00e8re dans les groupes cibles et mesure de l\u2019efficacit\u00e9 vaccinale. Couverture vaccinale par les vaccins dipht\u00e9rie-t\u00e9tanos-poliomy\u00e9lite (dTP) et antipneumococcique chez les personnes \u00e2g\u00e9es de 65 ans et plus. Saint-Maurice: Institut de veille sanitaire; 2011. 21 p."},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.077_b0150","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.vaccine.2011.12.011","article-title":"Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010\u20132011","volume":"30","author":"Guthmann","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0155","unstructured":"Sant\u00e9 Publique France. Donn\u00e9es r\u00e9gionales de couverture vaccinale grippe par saison et dans chaque groupe d\u2019\u00e2ge. Acc\u00e8s Internet le 31\/03\/2020: https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/articles\/donnees-regionales-de-couverture-vaccinale-grippe-par-saison-et-dans-chaque-groupe-d-age."},{"key":"10.1016\/j.vaccine.2024.04.077_b0160","unstructured":"Sant\u00e9 Publique France. Donn\u00e9es de couverture vaccinale m\u00e9ningocoque C par groupe d\u2019\u00e2ge. Acc\u00e8s Internet le 20\/03\/2020: https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/articles\/donnees-de-couverture-vaccinale-meningocoque-c-par-groupe-d-age."},{"key":"10.1016\/j.vaccine.2024.04.077_b0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bjid.2017.03.021","article-title":"Vaccination coverage in a cohort of HIV-infected patients receiving care at an AIDS outpatient clinic in Esp\u00edrito Santo, Brazil","volume":"21","author":"da S. Pinto Neto","year":"2017","journal-title":"The Brazilian Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2024.04.077_b0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.medmal.2010.06.005","article-title":"Insuffisance de couverture vaccinale d\u2019une cohorte fran\u00e7aise de patients s\u00e9ropositifs VIH","volume":"40","author":"Mohseni-Zadeh","year":"2010","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.vaccine.2024.04.077_b0175","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1542\/peds.2007-0538","article-title":"Parents with doubts about vaccines: which vaccines and reasons why","volume":"122","author":"Gust","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.04.077_b0180","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2010.01.027","article-title":"Positive attitudes of French general practitioners towards A\/H1N1 influenza-pandemic vaccination: a missed oppor- tunity to increase vaccination uptakes in the general public?","volume":"28","author":"Schwarzinger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0185","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1503\/cmaj.121028","article-title":"The association between physicians\u2019 and patients\u2019 preventive health practices","volume":"185","author":"Frank","year":"2013","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2024.04.077_b0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.respe.2014.07.003","article-title":"Seasonal influenza vaccination coverage of general practitioners and their patients. Practice survey of French general practi- tioners after vaccination campaign 2011\u20132012","volume":"62","author":"Joseph","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.vaccine.2024.04.077_b0195","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1016\/j.vaccine.2014.10.026","article-title":"Determinants of influenza vaccination coverage rates among primary care patients in Krakow, Poland and the surrounding region","volume":"32","author":"Nessler","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0200","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.vaccine.2010.12.097","article-title":"Primary care physician perspectives on providing adult vaccines","volume":"29","author":"Freed","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0205","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2006.05.010","article-title":"What maintains parental support for vaccination when challenged by anti-vaccination mes- sages? A qualitative study","volume":"24","author":"Leask","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2024.04.077_b0210","article-title":"How to optimise the coverage rate of infant and adult immunisations in Europe","volume":"5","author":"Schmitt","year":"2007","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2024.04.077_b0215","unstructured":"AVNIR. Vaccination des personnes \u00e0 risque d\u2019infections. Acc\u00e8s Internet le 31\/03\/2020: https:\/\/www.avnirvaccination.fr\/documents\/Reunion-AVNIR_31032016.pdf."},{"key":"10.1016\/j.vaccine.2024.04.077_b0220","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","article-title":"Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study","volume":"396","author":"de Figueiredo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.04.077_b0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3201\/eid2901.221151","article-title":"COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022","volume":"29","author":"Lu","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.077_b0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1057\/s41599-023-01593-2","article-title":"COVID-19 vaccine communication and advocacy strategy: a social marketing campaign for increasing COVID-19 vaccine uptake in South Korea","volume":"10","author":"Hong","year":"2023","journal-title":"Humanit Soc Sci Commun"},{"key":"10.1016\/j.vaccine.2024.04.077_b0235","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and gender differences in the outcomes of vaccination over the life course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2024.04.077_b0240","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2011.06.107","article-title":"Factors associated with uptake of vaccination against pandemic influenza: a systematic review","volume":"29","author":"Bish","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0245","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1016\/j.vaccine.2013.06.039","article-title":"Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey","volume":"31","author":"Pulcini","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0250","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1016\/j.vaccine.2010.07.029","article-title":"Gender influence in influenza vaccine uptake in Spain: time trends analysis (1995\u20132006)","volume":"28","author":"Jim\u00e9nez-Garc\u00eda","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.077_b0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0140-6736(13)60955-1","article-title":"What does universal health coverage mean?","volume":"383","author":"O\u2019Connell","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2024.04.077_b0260","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/hiv.12483","article-title":"Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey","volume":"18","author":"Harrison","year":"2017","journal-title":"HIV Med"},{"key":"10.1016\/j.vaccine.2024.04.077_b0270","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ajic.2017.10.004","article-title":"Vaccination coverage in patients affected by chronic diseases: A 2014 cross-sectional study among subjects hospitalized at Bari Policlinico General Hospital","volume":"46","author":"Gallone","year":"2018","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2024.04.077_b0275","doi-asserted-by":"crossref","first-page":"E542","DOI":"10.1503\/cmaj.091304","article-title":"Seasonal influenza vaccination campaigns for health care personnel: systematic review","volume":"182","author":"Lam","year":"2010","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2024.04.077_b0280","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/irv.12002","article-title":"Review: interventions to increase influenza vaccination among healthcare workers in hospitals: Increasing HCW influenza vaccination","volume":"7","author":"Hollmeyer","year":"2013","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2024.04.077_b0285","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.annemergmed.2004.07.406","article-title":"Seroprevalence for tetanus antibodies among immigrants over age 50: comparison to an age matched US born population","volume":"44","author":"Alagappan","year":"2004","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.vaccine.2024.04.077_b0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12245-008-0020-8","article-title":"Tetanus antibody protection amongHIV-infected US-born patients and immigrants","volume":"1","author":"Alagappan","year":"2008","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.vaccine.2024.04.077_b0295","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0020731416637174","article-title":"Restricting access to health care to immigrants in Barcelona: A mixed-methods study with immigrants who have experienced an infectious disease","volume":"46","author":"Castano","year":"2016","journal-title":"Int J Health Serv"},{"key":"10.1016\/j.vaccine.2024.04.077_b0300","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/jan.15222","article-title":"A large cross-sectional survey of COVID -19 vaccination willingness amongst healthcare students and professionals: Reveals generational patterns","volume":"78","author":"Tomietto","year":"2022","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.vaccine.2024.04.077_b0305","unstructured":"Courrier au Directeur g\u00e9n\u00e9ral de la sant\u00e9, Pr J\u00e9r\u00f4me Salomon du 14 mars 2020. Haut Conseil de la Sant\u00e9 Publique."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T06:43:39Z","timestamp":1720853019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":60,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0264410X24005164"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insufficient vaccine coverage and vaccine hesitancy in people living with HIV: A prospective study in outpatient clinics in the Paris region","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}